article thumbnail

NRx Pharmaceuticals Applies for FDA National Priority Voucher for Intravenous Ketamine (NRX-100)

Psychiatric Times

1 The newly announced CNPV pathway was introduced by FDA Commissioner Marty Makary, MD, MPH, on June 17, 2025, and is intended to expedite reviews for medications that address US public health priorities. The CNPV program, introduced by FDA Commissioner Marty Makary, aims to reduce review times to 1-2 months for eligible applications.

article thumbnail

The 2025 Summer Heatwave: Implications for Patients With Psychiatric Disorders

Psychiatric Times

Ms Barbee has a passion to reduce the stigma around mental health and promoting increased access to mental health care and education of both clinicians and the general public. She has also served as advisory board participant for Supernus Pharmaceuticals and Axsome Therapeutics. Goldberg, MD, and Anita H.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Tardive Dyskinesia: Treat Functional Impairment, Not the AIMS Score

Psychiatric Times

of patients who were prescribed antipsychotics for their psychiatric illness and had evidence of tardive dyskinesia (TD) had TD recorded properly in their electronic health records, supporting the idea that TD is often underreported and misdiagnosed and, therefore, not treated appropriately. References 1. Griffiths K, Won Y, Lee Z, et al.

article thumbnail

FDA Requires New Label Warning of Weight Loss Risk in Pediatric Patients Taking Extended-Release Stimulants for ADHD

Psychiatric Times

SHOW MORE The FDA will update ADHD medication labels, warning of weight loss risks in children under 6, urging careful monitoring by health care professionals. Health care professionals should monitor the child’s growth and development and provide necessary interventions to mitigate weight loss.” FDA Drug Safety Communication.

article thumbnail

How Do Psychiatry Residents Learn Psychopharmacology?

Psychiatric Times

Division of Clinical Pharmacology, Indiana University School of Medicine Updated 2021. Flockhart DA, Thacker D, McDonald C, et al. The Flockhart Cytochrome P450 Drug-Drug Interaction Table. Accessed June 11, 2025. Goldberg, MD, and Anita H. Goldberg, MD, and Anita H.

Education 123
article thumbnail

Dismissing the “Human Experience”: College Students Feel Unseen by the Medical Model of Mental Health

Mad in America

In a previous story , I reported on the “TikTokification” of mental health —a phenomenon where social media content encourages young people to self-diagnose. Many students find comfort in the medical model of mental health because it simplifies experiences that are otherwise messy, uncomfortable, and difficult to make sense of. “I

article thumbnail

Study: Vitamin D Insufficiency Worsens Sleep Problems in Children with ADHD

ADDitude

April 29, 2025 Vitamin D insufficiency worsens sleep problems in children with ADHD, but it does not directly affect the condition’s symptoms or functional impairments, a recent study published in Frontiers in Psychology found. Nearly three-quarters of children with ADHD experience a sleep problem or disorder.